Roman Butler Fullerton & Co. Makes New $1.28 Million Investment in Rocket Lab Corporation $RKLB

Roman Butler Fullerton & Co. acquired a new stake in shares of Rocket Lab Corporation (NASDAQ:RKLB) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 16,628 shares of the rocket manufacturer’s stock, valued at approximately $1,276,000.

A number of other institutional investors also recently bought and sold shares of RKLB. Mcguire Capital Advisors Inc. purchased a new stake in Rocket Lab in the 4th quarter worth approximately $27,000. Beacon Investment Advisory Services Inc. raised its position in shares of Rocket Lab by 364.0% in the second quarter. Beacon Investment Advisory Services Inc. now owns 399 shares of the rocket manufacturer’s stock valued at $41,000 after buying an additional 313 shares during the last quarter. Zions Bancorporation National Association UT acquired a new stake in shares of Rocket Lab in the fourth quarter valued at approximately $28,000. Gordian Capital Singapore Pte Ltd purchased a new position in shares of Rocket Lab during the 4th quarter worth $29,000. Finally, Reflection Asset Management purchased a new position in Rocket Lab during the fourth quarter worth about $30,000. 71.78% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Rocket Lab

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab secured a $397 million Space Force contract to deploy Flatellite low-Earth-orbit systems for airborne threat tracking. The award lifts the company’s reported 2026 U.S. defense contract total to approximately $943 million and strengthens its government and national-security business. Rocket Lab Stock: Slightly Drop as Space Force Awards $397M Deal for Flatellites
• Positive Sentiment: The Space Force also awarded Rocket Lab approximately $12 million for an orbital data network, adding to evidence of growing defense demand for its launch and space-systems capabilities. The company’s HASTE and GHOST offerings may provide additional opportunities in hypersonic testing and defense missions. RKLB Stock Gains Overnight: Rocket Lab Advances Neutron and Wins New Space Force Deal
• Positive Sentiment: Rocket Lab reported record second-quarter revenue of $234.1 million, up 62% year over year, while next-quarter revenue guidance of about $257.5 million reportedly exceeded expectations. Its backlog reached roughly $2.4 billion, supporting the long-term growth outlook. RKLB Q2 Deep Dive: Iridium Acquisition, Neutron Progress, and Margin Pressures Shape Outlook
• Positive Sentiment: KeyBanc, Stifel and other analysts remain constructive, with recent price targets ranging from approximately $115 to $135 and a reported consensus implying substantial upside. How Much Upside Is Left in Rocket Lab Corporation?
• Neutral Sentiment: Regulatory progress on the proposed Iridium acquisition continued after the U.S. antitrust waiting period expired and required filings were submitted. However, Rocket Lab is arranging approximately $3.6 billion of financing, making the transaction’s execution and leverage important investor risks. Rocket Lab Clears a Major Hurdle on the Iridium Acquisition
• Negative Sentiment: Despite the revenue beat, Rocket Lab’s quarterly loss was wider than expected. Investors are also concerned that the highly anticipated first Neutron flight could slip into 2027, delaying a key catalyst and leaving the stock’s premium valuation vulnerable. Rocket Lab’s Highly Anticipated Neutron Flight May Be Delayed
• Negative Sentiment: The company authorized a replacement $1.94 billion at-the-market stock offering to help fund the Iridium transaction and reduce debt needs. Although the total authorization was not increased, future share issuance could dilute existing holders. Insiders have also reported extensive selling with no purchases in the past six months. Rocket Lab Announces Replacement At-the-Market Equity Program

Rocket Lab Stock Performance

Shares of RKLB opened at $80.25 on Monday. Rocket Lab Corporation has a twelve month low of $37.57 and a twelve month high of $151.00. The company has a current ratio of 5.48, a quick ratio of 4.98 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $48.02 billion, a P/E ratio of -297.21 and a beta of 2.60. The firm’s 50-day moving average is $85.09 and its two-hundred day moving average is $85.52.

Rocket Lab (NASDAQ:RKLB) last released its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.06) by ($0.02). Rocket Lab had a negative net margin of 21.51% and a negative return on equity of 6.48%. The firm had revenue of $234.07 million during the quarter, compared to analysts’ expectations of $231.62 million. On average, research analysts predict that Rocket Lab Corporation will post -0.25 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, insider Frank Klein sold 36,860 shares of Rocket Lab stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $147.42, for a total transaction of $5,433,901.20. Following the completion of the sale, the insider owned 1,006,987 shares in the company, valued at approximately $148,450,023.54. This trade represents a 3.53% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Alexander R. Slusky sold 40,000 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $123.60, for a total transaction of $4,944,000.00. Following the sale, the director directly owned 334,675 shares in the company, valued at $41,365,830. This represents a 10.68% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 3,749,294 shares of company stock valued at $351,008,208. Corporate insiders own 8.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. Needham & Company LLC reaffirmed a “buy” rating on shares of Rocket Lab in a research report on Tuesday, August 11th. New Street Research initiated coverage on Rocket Lab in a research note on Wednesday, May 13th. They set a “buy” rating and a $150.00 target price for the company. TD Cowen boosted their price target on shares of Rocket Lab from $90.00 to $120.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Weiss Ratings restated a “sell (d-)” rating on shares of Rocket Lab in a research note on Friday, July 17th. Finally, Bank of America raised their price objective on Rocket Lab from $105.00 to $115.00 and gave the stock a “buy” rating in a report on Tuesday, June 30th. Three investment analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $110.65.

About Rocket Lab

Rocket Lab is an aerospace company that provides launch services, spacecraft, and space systems for commercial and government customers. The company’s primary launch vehicle is Electron, a small-lift orbital rocket designed to deploy small satellites and rideshare payloads to low Earth orbit. Rocket Lab also develops and manufactures the Rutherford engine, noted for its electric-pump-fed design and additive-manufactured components, which powers Electron and supports the company’s propulsion capabilities.